Found: 39
Select item for more details and to access through your institution.
Targeting pathobionts for the treatment of alcohol‐associated liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 239, doi. 10.1111/liv.14723
- By:
- Publication type:
- Article
Reply to: Pulmonary function is associated with fibrosis severity in patients with biopsy‐proven nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 243, doi. 10.1111/liv.14742
- By:
- Publication type:
- Article
Pathophysiological mechanisms of liver injury in COVID‐19.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 20, doi. 10.1111/liv.14730
- By:
- Publication type:
- Article
Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 230, doi. 10.1111/liv.14715
- By:
- Publication type:
- Article
COVID‐19 and liver disease: Not all evil comes to harm.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 237, doi. 10.1111/liv.14721
- By:
- Publication type:
- Article
Author response to Letter to the Editor: Hepatitis E prevalence in indigenous communities from Western Brazilian Amazon.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 234, doi. 10.1111/liv.14717
- By:
- Publication type:
- Article
The association of low‐grade albuminuria with incident nonalcoholic fatty liver disease and non‐invasive markers of liver fibrosis.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 220, doi. 10.1111/liv.14693
- By:
- Publication type:
- Article
The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 16, doi. 10.1111/liv.14729
- By:
- Publication type:
- Article
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 110, doi. 10.1111/liv.14714
- By:
- Publication type:
- Article
Genetic insight into COVID‐19‐related liver injury.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 227, doi. 10.1111/liv.14708
- By:
- Publication type:
- Article
The time has come to look for metabolic dysfunction‐associated fatty liver disease in adult patients with type 1 Gaucher disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 224, doi. 10.1111/liv.14707
- By:
- Publication type:
- Article
Response to comment on: Optic nerve sheath diameter in children with acute liver failure: A prospective observational pilot study.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 231, doi. 10.1111/liv.14716
- By:
- Publication type:
- Article
Author response to Letter to the Editor: MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 221, doi. 10.1111/liv.14705
- By:
- Publication type:
- Article
Pulmonary function is associated with fibrosis severity in patients with biopsy‐proven nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 245, doi. 10.1111/liv.14704
- By:
- Publication type:
- Article
CK‐18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 123, doi. 10.1111/liv.14699
- By:
- Publication type:
- Article
Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 70, doi. 10.1111/liv.14698
- By:
- Publication type:
- Article
Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 192, doi. 10.1111/liv.14706
- By:
- Publication type:
- Article
The biological process of lysine‐tRNA charging is therapeutically targetable in liver cancer.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 206, doi. 10.1111/liv.14692
- By:
- Publication type:
- Article
MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 223, doi. 10.1111/liv.14691
- By:
- Publication type:
- Article
The global trends and regional differences in incidence of HEV infection from 1990 to 2017 and implications for HEV prevention.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 58, doi. 10.1111/liv.14686
- By:
- Publication type:
- Article
A pregnant woman with congenital hepatic fibrosis delivers a healthy neonate.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 128, doi. 10.1111/liv.14683
- By:
- Publication type:
- Article
HCV cirrhotic patients treated with direct‐acting antivirals: Detection of tubular dysfunction and resolution after viral clearance.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 158, doi. 10.1111/liv.14672
- By:
- Publication type:
- Article
Rates and characteristics of SARS‐CoV‐2 infection in persons with hepatitis C virus infection.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 76, doi. 10.1111/liv.14681
- By:
- Publication type:
- Article
Factors associated with health‐related quality of life in patients with cirrhosis: a systematic review.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 6, doi. 10.1111/liv.14680
- By:
- Publication type:
- Article
Hepatitis E prevalence in indigenous communities from Western Brazilian Amazon.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 235, doi. 10.1111/liv.14679
- By:
- Publication type:
- Article
Non‐selective beta‐blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow‐up.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 168, doi. 10.1111/liv.14674
- By:
- Publication type:
- Article
Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 180, doi. 10.1111/liv.14682
- By:
- Publication type:
- Article
Impact of metabolic risk factors on the severity and outcome of patients with alcohol‐associated acute‐on‐chronic liver failure.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 150, doi. 10.1111/liv.14671
- By:
- Publication type:
- Article
Peri‐complication diagnosis of hepatitis C infection: Risk factors and trends over time.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 33, doi. 10.1111/liv.14670
- By:
- Publication type:
- Article
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 133, doi. 10.1111/liv.14667
- By:
- Publication type:
- Article
Concerning 'Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease' by Nascimbeni et al.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 226, doi. 10.1111/liv.14668
- By:
- Publication type:
- Article
The potential missing links between hepatoprotective dioscin and alcoholic liver disease.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 241, doi. 10.1111/liv.14665
- By:
- Publication type:
- Article
Optic nerve sheath diameter in children with acute liver failure and hepatic encephalopathy.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 233, doi. 10.1111/liv.14624
- By:
- Publication type:
- Article
Tuberculosis presenting as a liver mass in a pregnant lady.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 204, doi. 10.1111/liv.14651
- By:
- Publication type:
- Article
A tool to predict progression of non‐alcoholic fatty liver disease in severely obese patients.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 91, doi. 10.1111/liv.14650
- By:
- Publication type:
- Article
The association of low‐grade albuminuria with incident non‐alcoholic fatty liver disease and non‐invasive markers of liver fibrosis by glycaemia status.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 101, doi. 10.1111/liv.14649
- By:
- Publication type:
- Article
Long‐term clinical outcome of HBeAg‐negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 48, doi. 10.1111/liv.14654
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 1, doi. 10.1111/liv.14520
- Publication type:
- Article
The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 81, doi. 10.1111/liv.14637
- By:
- Publication type:
- Article